Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Nova Biomedical Corporation has 2 pending office actions in Chemistry & Materials. The matters involve 2 examiners and 2 art units, so each follows a separate examination path.
SUN, CAITLYN MINGYUN is the busiest examiner, with 1 pending matter. No examiner concentration is shown. Counsel can review each matter independently while checking whether the separate art-unit assignments produce consistent treatment of related claim concepts.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SUN, CAITLYN MINGYUN | 1 | 63.7% | +11.8% |
| REGLAS, GEORGIANA C | 1 | 39.2% | +33.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17767143 | COAGULATION ASSAY APPARATUS AND METHODS THEREOF | REGLAS, GEORGIANA C | 9d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17767143 | COAGULATION ASSAY APPARATUS AND METHODS THEREOF | REGLAS, GEORGIANA C | 9d overdue |
| 19196255 | Single-use disposable reference sensor | SUN, CAITLYN MINGYUN | — |
| Art Unit | Apps |
|---|---|
| 1795 | 1 |
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19196255 | Single-use disposable reference sensor | SUN, CAITLYN MINGYUN | 1795 | §103 | Non-Final OA | — | Pending | May 01, 2025 |
| 17767143 | COAGULATION ASSAY APPARATUS AND METHODS THEREOF | REGLAS, GEORGIANA C | 1651 | §103§112 | Non-Final OA | 9d overdue | Pending | Apr 07, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNova Biomedical Corporation has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Caitlyn Mingyun Sun has the most, with 1 of Nova Biomedical Corporation's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
